Cargando…
A Pooled Analysis Evaluating the Efficacy and Tolerability of Tapentadol Extended Release for Chronic, Painful Diabetic Peripheral Neuropathy
BACKGROUND AND OBJECTIVE: Data from two similarly designed studies of tapentadol extended release (ER) for managing neuropathic pain associated with diabetic peripheral neuropathy (DPN; NCT00455520, NCT01041859) in adults were pooled for this analysis, allowing a detailed evaluation of efficacy in p...
Autores principales: | Schwartz, Sherwyn, Etropolski, Mila S., Shapiro, Douglas Y., Rauschkolb, Christine, Vinik, Aaron I., Lange, Bernd, Cooper, Kimberly, Van Hove, Ilse, Haeussler, Juergen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300409/ https://www.ncbi.nlm.nih.gov/pubmed/25503082 http://dx.doi.org/10.1007/s40261-014-0249-3 |
Ejemplares similares
-
Evaluation of Blood Pressure and Heart Rate in Patients with Hypertension Who Received Tapentadol Extended Release for Chronic Pain: A Post Hoc, Pooled Data Analysis
por: Biondi, David M., et al.
Publicado: (2014) -
Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release
por: Imanaka, Keiichiro, et al.
Publicado: (2014) -
First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18
por: Finkel, Julia C, et al.
Publicado: (2019) -
Tapentadol extended release for the management of chronic neck pain
por: Billeci, Domenico, et al.
Publicado: (2017) -
Tapentadol extended-release for treatment of chronic pain: a review
por: Vadivelu, Nalini, et al.
Publicado: (2011)